Literature DB >> 8037256

Six-month stability of psychiatric diagnoses in first-admission patients with psychosis.

S Fennig1, B Kovasznay, C Rich, R Ram, C Pato, A Miller, J Rubinstein, G Carlson, J E Schwartz, J Phelan.   

Abstract

OBJECTIVE: The short-term diagnostic stability of schizophrenic and other psychotic disorders was examined in first-admission patients, with attention to the principal reasons for diagnostic change.
METHOD: Hospitalized first-admission patients (N = 278) participating in an epidemiologic study were interviewed at baseline and after 6 months with the Structured Clinical Interview for DSM-III-R. A best estimate diagnosis was made at both time points with the use of all available sources of information. Reasons for changes in diagnosis were determined by two psychiatrists.
RESULTS: Affective psychosis and schizophrenic disorders were relatively stable broad diagnostic categories over the 6-month period, with 86.5%-88.9% of the patients remaining in the same category, although findings for specific diagnoses within these categories ranged from 61.5% to 85.7%. The groups with unknown and nonspecific diagnoses showed less stability; the diagnoses of more than one-third of these patients remained unknown or nonspecific at the 6-month evaluation. If the 6-month diagnoses are used as the research standard, somewhat lower percentages of patients received the same diagnoses at baseline. Forty-three percent of the changes in diagnosis were attributed to the clinical course of illness; the rest were attributed to the diagnostic process itself.
CONCLUSIONS: A longitudinal diagnostic assessment based on multiple sources of information is crucial for categorizing first-admission psychotic patients, particularly those who do not initially fit into a DSM-III-R category. The short-term stability of a diagnosis is a function of multiple factors, including the changing clinical picture, additional sources of information, and new interpretations of original data.

Entities:  

Mesh:

Year:  1994        PMID: 8037256     DOI: 10.1176/ajp.151.8.1200

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Authors:  Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

2.  Exploring boundaries of schizophrenia: a comparison of ICD-10 with other diagnostic systems in first-admitted patients.

Authors:  Lennart Jansson; Peter Handest; Jan Nielsen; Ditte Sæbye; Josef Parnas
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

3.  The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients.

Authors:  Won Kim; Young Sup Woo; Jeong-Ho Chae; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-12-31       Impact factor: 2.582

4.  Diagnostic shifts during the decade following first admission for psychosis.

Authors:  Evelyn J Bromet; Roman Kotov; Laura J Fochtmann; Gabrielle A Carlson; Marsha Tanenberg-Karant; Camilo Ruggero; Su-wei Chang
Journal:  Am J Psychiatry       Date:  2011-06-15       Impact factor: 18.112

5.  Ten-year diagnostic consistency of bipolar disorder in a first-admission sample.

Authors:  Camilo J Ruggero; Gabrielle A Carlson; Roman Kotov; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

6.  Diagnosis and six-month stability of negative symptoms in psychotic disorders.

Authors:  S Fennig; E J Bromet; N Galambos; K Putnam
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

7.  Diagnostic consistency of major depression with psychosis across 10 years.

Authors:  Camilo J Ruggero; Roman Kotov; Gabrielle A Carlson; Marsha Tanenberg-Karant; David A González; Evelyn J Bromet
Journal:  J Clin Psychiatry       Date:  2011-08-09       Impact factor: 4.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.